Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Andreas Busch

- PMLiVE

Bayer’s Xarelto wins another NICE recommendation

Deemed cost-effective use of NHS resources to prevent blood clots following a heart attack

- PMLiVE

AbbVie and Shire bring merger plans to a close

Blames tax changes in the US

- PMLiVE

AbbVie board recommends dropping Shire deal

Tells stakeholders to vote against merger in light of new rules on corporate tax

- PMLiVE

AbbVie rethinks Shire merger in light of US tax crackdown

Follows action to discourage 'inversion deals' aimed at reducing corporate tax rates

- PMLiVE

Pharma supports first World Thrombosis Day

Aims to raise awareness of the blood clot condition

- PMLiVE

Otmar Wiestler appointed to Bayer supervisory board

He replaces Klaus Kleinfeld

Shire Basingstoke

Shire reaches $56.5m US marketing malpractice settlement

Justice Department agreement covers activities for drugs including Adderall

Bayer symbol

Bayer to spin out material science division

German firm will focus solely on life sciences

- PMLiVE

Bayer partners with Glamour on female empowerment

Campaign to support the contraception Skyla

Bayer symbol

Bayer wins GIST approval for Stivarga in EU

Cancer drug can be used after Pfizer’s Sutent and Novartis’ Glivec

- PMLiVE

Nexavar fails late-stage breast cancer trial

Bayer’s oncology drug unable to improve progression free survival in new indication

- PMLiVE

It’s on: Shire and AbbVie agree £32bn takeover

Companies agree deal that is set to cut US pharma company’s corporate tax bill

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links